AbbVie’s positive eczema study drags down Regeneron’s shares – Reuters


Reuters
AbbVie's positive eczema study drags down Regeneron's shares
Reuters
AbbVie Inc said on Thursday its experimental drug to treat adults with moderate-to-severe eczema met the main goal in a mid-stage study, dragging down …
AbbVie Inc (ABBV) Stock Surges on Positive Eczema StudyInvestorplace.com
AbbVie shares rally on positive eczema study, competitor Regeneron dropsInvesting.com
Abbvie shares rising in New York on eczema drug newsProactive Investors USA & Canada
Madison.com –Investor’s Business Daily –nwitimes.com –Zacks Investment Research
all 144 news articles »

eczema – Google News

Eczema Free Foreverâ„¢